Literature DB >> 16015427

Apical hypertrophic cardiomyopathy: a case of slow flow in lad and malign ventricular arrhythmia.

Emre Aksakal1, Oktay Yapici, Mustafa Yazici, Ozcan Yilmaz, Mahmut Sahin.   

Abstract

The coronary slow flow phenomenon is an angiographic finding characterized by delayed distal vessel opacification in the absence of epicardial coronary artery disease. Patients often present with acute coronary syndrome. Histopathologic studies have revealed the existence of fibromuscular hyperplasia and myofibrilar hypertrophy. Apical hypertrophic cardiomyopathy is a benign progressive form of hypertrophic cardiomyopathy, that is rarely observed in western communities. It remains commonly asymptomatic until advanced ages. Syncope, arrhythmia or sudden death may be the first symptom. We report a case of slow coronary arterial flow in a 71-year-old male patient with apical hypertrophic cardiomyopathy who experienced chest pain and sudden cardiac arrest due to ventricular arrhythmia.

Entities:  

Mesh:

Year:  2005        PMID: 16015427     DOI: 10.1007/s10554-004-2457-z

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  10 in total

1.  Angina pectoris and slow flow velocity of dye in coronary arteries--a new angiographic finding.

Authors:  A A Tambe; M A Demany; H A Zimmerman; E Mascarenhas
Journal:  Am Heart J       Date:  1972-07       Impact factor: 4.749

2.  Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features.

Authors:  P J Counihan; L Fei; Y Bashir; T G Farrell; G A Haywood; W J McKenna
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

3.  Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.

Authors:  M P Frenneaux; P J Counihan; A L Caforio; T Chikamori; W J McKenna
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

4.  Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries.

Authors:  M Mosseri; R Yarom; M S Gotsman; Y Hasin
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

5.  Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates.

Authors:  J G Webb; Z Sasson; H Rakowski; P Liu; E D Wigle
Journal:  J Am Coll Cardiol       Date:  1990-01       Impact factor: 24.094

6.  Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction.

Authors:  R Lorenzoni; R Gistri; F Cecchi; I Olivotto; G Chiriatti; P Elliott; W J McKenna; P G Camici
Journal:  Am Heart J       Date:  1998-12       Impact factor: 4.749

7.  Apical hypertrophic cardiomyopathy: clinical and two-dimensional echocardiographic assessment.

Authors:  E K Louie; B J Maron
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

8.  "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death.

Authors:  B J Maron; L C Lipson; W C Roberts; D D Savage; S E Epstein
Journal:  Am J Cardiol       Date:  1978-06       Impact factor: 2.778

9.  TIMI frame count: a quantitative method of assessing coronary artery flow.

Authors:  C M Gibson; C P Cannon; W L Daley; J T Dodge; B Alexander; S J Marble; C H McCabe; L Raymond; T Fortin; W K Poole; E Braunwald
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

10.  Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study.

Authors:  T Sakamoto; C Tei; M Murayama; H Ichiyasu; Y Hada
Journal:  Jpn Heart J       Date:  1976-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.